Posted on 7th May 202016th July 2021 by Bernardo Cortese Posted in Current research on Drug-Coated Balloons, Presentations at international/national scientific meetings Leave a comment OCT, DCB and BRS technologies: my interview during IndiaLive2019 Check it out! https://www.youtube.com/watch?v=-zvuZd28-0o&feature=youtu.be BRS, DCB, indialive, indialive2019, interview, OCT 7th May 2020 in Current research on Drug-Coated Balloons, Presentations at international/national scientific meetingsAngioplastica coronarica: i benefici del pallone medicato7th May 2020 in Current research on Drug-Coated Balloons, Presentations at international/national scientific meetingsDCB ROUNDTABLE7th May 2020 in Current research on Drug-Coated Balloons, Presentations at international/national scientific meetingsReply letter to Piccoleto II : seeking an appropriate primary endpoint for DCB clinical trials7th May 2020 in Current research on Drug-Coated Balloons, Presentations at international/national scientific meetingsIs Paclitaxel-Eluting Stent Use Justified by an Adequate Risk Profile?7th May 2020 in Current research on Drug-Coated Balloons, Presentations at international/national scientific meetingsFocus on Drug coated balloons – Summeet Webinar7th May 2020 in Current research on Drug-Coated Balloons, Presentations at international/national scientific meetingsSeQuent Please NEO “DCB ONLY APPROACH”: publish or Up-To-Date Scientific Data – B.Braun 2020 Webinar7th May 2020 in Current research on Drug-Coated Balloons, Presentations at international/national scientific meetingsDCB in de novo lesions – CardioAlex 20 Webinar7th May 2020 in Current research on Drug-Coated Balloons, Presentations at international/national scientific meetingsWEBINAR: Sirolimus-coated balloons, an appraisal on its potential advantages over paclitaxel7th May 2020 in Current research on Drug-Coated Balloons, Presentations at international/national scientific meetingsEASTBOURNE registry finished the enrollment Leave a comment Cancel replyYou must be logged in to post a comment.